Matricelf Ltd.
MTLF
Rank in Stocks
#25381
Matricelf Ltd, a biotechnology company, develops a platform for autologous... Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. The company has a strategic collaboration with Sheba Medical Center for the development and clinical advancement of its neural tissue implant product for the treatment of spinal cord injury. The company has a strategic collaboration with CiRA Foundation for the development of regenerative manufacturing technologies and the evaluation of iPSC-based neural tissue engineering for therapeutic applications. The company was incorporated in 2019 and is based in Ness Ziona, Israel.
Share Price
$0.76136749
Last synced: 2026-11-09
Market Cap
$26.26M
Change (1 day)
2.74%
Change (1 year)
-42.68%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Matricelf Ltd. (MTLF)
Category
Healthcare
EPS for Matricelf Ltd. (MTLF)
EPS as of June 2026 TTM: $-0.57
According to Matricelf Ltd.'s latest financial reports, its current EPS (TTM) is $-0.57. At the end of 2025 the company had an EPS of $-0.47, a decrease compared to its 2024 EPS of $-0.27.
EPS history for Matricelf Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.57 | 21.26% |
| 2025 | $-0.47 | 76.66% |
| 2024 | $-0.27 | -99.89% |
| 2023 | $-247.04 | 91,635.54% |
| 2022 | $-0.27 | -55.41% |
| 2021 | $-0.60 | 646.60% |
| 2020 | $-0.08 | 317.01% |
| 2019 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -2,847.85% |
US
|
|
| $-7.07 | 1,140.57% |
US
|
|
| $-5.29 | 828.23% |
AU
|
|
| $12.88 | -2,360.06% |
BE
|
|
| $21.56 | -3,883.12% |
NL
|
Questions about Matricelf Ltd.'s earnings per share (EPS)
What is Matricelf Ltd.'s earnings per share (EPS)?
Matricelf Ltd.'s earnings per share (EPS) over the last twelve months is $-0.57, as of Jun 2026.
What was Matricelf Ltd.'s earnings per share (EPS) in 2025?
In 2025, Matricelf Ltd.'s earnings per share (EPS) was $-0.47, compared with $-0.27 in 2024.
How has Matricelf Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Matricelf Ltd.'s earnings per share (EPS) was highest in 2020 ($-0.08) and lowest in 2023 ($-247.04).
How does Matricelf Ltd.'s earnings per share (EPS) compare with similar companies?
Matricelf Ltd.'s earnings per share (EPS) ($-0.57) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.